Urinary Disorders in Subacute Patients After Stroke

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Rehabilitation Institute, Republic of Slovenia

About this trial

This observational study will address urinary disorders in subacute stroke patients. Patients without and with urinary disorders will be compared, and treatment outcome will be assessed among the latter.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

subacute patients after ischaemic or hemorrhagic stroke;

direct transfer from acute hospital to complex inpatient rehabilitation at our Institute.

Disqualifiers

incontinence before stroke;

previous brain injury or other brain disease;

previous bladder or prostate surgery;

inability to ambulate before stroke;

Trial population

Subacute patients after ischaemic or hemorrhagic stroke directly transferred from an acute hospital to complex inpatient rehabilitation

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Immediate urination

    Behavioral

    Patients with decreased cognitive ability will be taught to immediately go to the toilet upon feeling the urge to urinate and to be independent in urinating.

  • Bladder diary

    Behavioral

    Patients with normal cognitive abilities will be instructed to go to the toilet every 2-3 hours regardless of the urge to urinate

Treatment groups

250 Participants
are divided into 2 treatment groups
Group A: Without urinary disorders0 interventions
Group B: With urinary disorders2 interventions

Trial outcomes

Primary outcomes

1

Degree of urinary continence

Urinary continence will be assessed daily by the nursing staff as either complete, partial or incontinence

Time frame
Through study completion, for an average of 6 weeks

Secondary outcomes

1

Presence of urinary-disorders-related complications

Pressure ulcers, falls and urinary infections caused by urinary disorders will be recorded

Time frame
Through study completion, for an average of 6 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.